These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7570993)

  • 21. Efficacy of choice of dialysis membrane.
    Koda Y; Suzuki M; Hirasawa Y
    Nephrol Dial Transplant; 2001; 16 Suppl 4():23-6. PubMed ID: 11402093
    [No Abstract]   [Full Text] [Related]  

  • 22. Thrombocytopenia associated with use of a biocompatible hemodialysis membrane: a case report.
    Post JB
    Am J Kidney Dis; 2010 Jun; 55(6):e25-8. PubMed ID: 20110145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biocompatible characteristics of high-performance membranes.
    Uda S; Mizobuchi M; Akizawa T
    Contrib Nephrol; 2011; 173():23-29. PubMed ID: 21865772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
    Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
    J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delayed graft function and its management in children.
    Grenda R
    Pediatr Nephrol; 2017 Jul; 32(7):1157-1167. PubMed ID: 27778091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of dialyzer biocompatibility in acute renal failure.
    Vanholder R; De Vriese A; Lameire N
    Blood Purif; 2000; 18(1):1-12. PubMed ID: 10686437
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of membranes on morbidity.
    Locatelli F
    Nephrol Dial Transplant; 1996; 11 Suppl 2():116-20. PubMed ID: 8804010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Approach to dialysis biocompatibility: evaluation through in vivo investigation of lymphocyte biology. A technical note.
    Stefoni S; Feliciangeli G; Nanni Costa A; Coli L; Cianciolo G; De Sanctis LB; Buscaroli A; Iannelli S; Mosconi G; Bonomini V
    Contrib Nephrol; 1993; 103():65-75. PubMed ID: 8354064
    [No Abstract]   [Full Text] [Related]  

  • 29. Introducing the biology of bioincompatibility in dialysis.
    Bonomini V
    Nephrol Dial Transplant; 1991; 6 Suppl 2():1-3. PubMed ID: 1866055
    [No Abstract]   [Full Text] [Related]  

  • 30. Complement activation by dialyzer membranes--in vitro assessment.
    Vienken J
    Artif Organs; 1986 Aug; 10(4):344. PubMed ID: 3753259
    [No Abstract]   [Full Text] [Related]  

  • 31. Artificial kidney: status of the art and new perspectives.
    Stefoni S; Cianciolo G; Colì L; Raimondi C; Dalmastri V; Donati G; Manna C; Grammatico F
    Artif Cells Blood Substit Immobil Biotechnol; 2003 May; 31(2):111-2. PubMed ID: 12751828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dialysis fluid and water: their roles in biocompatibility.
    Berland Y; Brunet P; Ragon A; Reynier JP
    Nephrol Dial Transplant; 1995; 10 Suppl 10():45-7. PubMed ID: 8825432
    [No Abstract]   [Full Text] [Related]  

  • 33. Highly permeable and biocompatible membranes and prevalence of dialysis-associated arthropathy.
    Kessler M; Netter P; Maheut H; Wolf C; Prenat E; Huu TC; Gaucher A
    Lancet; 1991 May; 337(8749):1092-3. PubMed ID: 1673510
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
    Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P
    Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immune response and immunomodulation in blood purification].
    Nakamura M; Hirasawa H; Hirano T; Nitta M
    Nihon Rinsho; 2004 May; 62 Suppl 5():50-4. PubMed ID: 15197887
    [No Abstract]   [Full Text] [Related]  

  • 36. Complement activation and leucopenia on cellulosic haemodialyzers: influence of the membrane area and role of hydroxyl moieties.
    Goldman M; Lietaer N; Lambert P; Thayse C; Vanherweghem JL
    Life Support Syst; 1987; 5(4):317-22. PubMed ID: 3501504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokines and bioincompatibility.
    Gesualdo L; Pertosa G; Grandaliano G; Schena FP
    Nephrol Dial Transplant; 1998 Jul; 13(7):1622-6. PubMed ID: 9681699
    [No Abstract]   [Full Text] [Related]  

  • 38. Dialysis without membranes: how and why?
    Leonard EF; West AC; Shapley NC; Larsen MU
    Blood Purif; 2004; 22(1):92-100. PubMed ID: 14732817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biocompatibility of dialysis membrane.
    Kes P
    Acta Med Croatica; 1999; 53(1):29-40. PubMed ID: 10437275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using AN69 ST membrane: a dialysis centre experience.
    Maheut H; Lacour F
    Nephrol Dial Transplant; 2001 Jul; 16(7):1519-20. PubMed ID: 11427664
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.